Objective To study the change of leukemia immuno-phenotypes before and after chemotherapy in patients with B-lineage acute lymphoblastic leukemia(B-ALL),and to provide a reference for determining B-ALL minimal residual disease (MRD)by flow cytometry(FCM). Methods The antigen positive rate and intensity changes of CD45,CD19,CD10,CD20,CD34,CD38,CD13 and CD33 determined by FCM were analyzed before and after chemotherapy among 226 B-ALL patients. Results The intensity changes from high to low were CD10,CD34,CD38,CD19,CD20 and CD45. The intensity changes of CD10 were significantly higher than those of CD38,CD19,CD20 and CD45(P<0.01),the intensity changes of CD34 were higher than those of CD19,CD20 and CD45(P<0.01),and the intensity changes of CD38 were higher than those of CD20 and CD45(P<0.01). In the 33rd day of chemotherapy,the enhanced proportions of CD34 and CD45 expression were higher than those in the 15th day(P<0.05). The changes of antigen positive rate from high to low were CD20,CD38,CD34,CD45,CD10 and CD19,and those of CD20 and CD38 were significantly higher than those of CD34,CD45,CD10 and CD19(P<0.01). In the 33rd day of chemotherapy,the loss proportion of CD38 was higher than that in the 15th day(P<0.01),and the gain proportion of CD34 was significantly higher than that in the 15th day(P<0.01). In the 15th day, the loss proportion of CD10 was lower than those in the 33rd day and 48th day(P<0.05). Most patients after chemotherapy had 1-4 antigens' expression changes. Conclusions After chemotherapy,the proportions of antigen positive rate and intensity changes for immuno-phenotypes are high in B-ALL patients. In the determination of MRD,it should consider phenotypes at primary diagnosis and their changes during chemotherapy.